Affine Formulations Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Affine Formulations

DeciZen not available for IPO

10 Year X-Ray of Affine Formulations:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17TTM
ROCE % 12.9%12.1%10%14.1%13.3%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 21.631.332.424.325.125
Sales YoY Gr.-45.4%3.5%-25.1%3.5%-
Adj EPS 1.31.20.61.81.61.6
YoY Gr.--12.2%-46.1%187.1%-8.4%-
BVPS (₹) 10.311.311.913.715.315.3
Adj Net
Profit
0.70.70.41.111
Cash Flow from Ops. 0.50.50.92.10.1-
Debt/CF from Ops. 18.919.911.54.5120-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-7.1%3.5%
Adj EPS NANA12.3%-8.4%
BVPSNANA10.7%11.8%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17TTM
Return on
Equity %
12.8115.413.911.210.7
Op. Profit
Mgn %
10.76.96.812.211.5NAN
Net Profit
Mgn %
3.42.21.24.43.93.9
Debt to
Equity
1.71.51.41.11.1-
Working Cap
Days
01821942672860
Cash Conv.
Cycle
01191261701880

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Affine Formulations Ltd.

Standalone Consolidated
TTM EPS (₹) 1.6 -
TTM Sales (₹ Cr.) 25.1 -
BVPS (₹.) 15.3 -
Reserves (₹ Cr.) 3 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 6
Face Value (₹) 10
Industry PE 43.4

Management X-Ray of Affine Formulations:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Affine Formulations

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17
Sales21.5531.3332.4324.2925.14
Operating Expenses 19.2529.1530.2321.3422.26
Manufacturing Costs0.360.390.430.240.25
Material Costs18.1327.8528.8020.1820.77
Employee Cost 0.590.680.760.690.82
Other Costs 0.170.240.240.220.42
Operating Profit 2.302.172.202.962.88
Operating Profit Margin (%) 10.7%6.9%6.8%12.2%11.5%
Other Income 0.020.060.050.040.11
Interest 1.211.211.211.051.12
Depreciation 0.300.270.580.580.57
Exceptional Items 00000
Profit Before Tax 0.810.750.461.381.30
Tax 0.070.060.090.310.33
Profit After Tax 0.740.690.371.070.98
PAT Margin (%) 3.4%2.2%1.2%4.4%3.9%
Adjusted EPS (₹)1.31.20.61.81.6
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17

Equity and Liabilities

Shareholders Fund 5.796.777.148.219.19
Share Capital 0.941116
Reserves 4.855.776.147.213.19
Minority Interest00000
Debt9.069.679.759.129.97
Long Term Debt4.605.274.644.615.42
Short Term Debt4.464.405.124.514.55
Trade Payables4.285.355.275.106.44
Others Liabilities 1.631.051.010.730.63
Total Liabilities 20.7522.8423.1723.1626.23

Fixed Assets

Gross Block7.247.287.287.357.54
Accumulated Depreciation1.371.642.222.803.36
Net Fixed Assets5.875.645.074.564.17
CWIP 00000
Investments 00000
Inventories6.358.468.739.468.16
Trade Receivables7.727.758.648.0813.18
Cash Equivalents 0.360.540.360.790.43
Others Assets0.450.450.370.270.28
Total Assets 20.7522.8423.1723.1626.23

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17
Cash Flow From Operating Activity 0.530.490.872.050.08
PBT 0.810.750.461.381.30
Adjustment 1.501.461.771.611.67
Changes in Working Capital -1.78-1.71-1.22-0.55-2.47
Tax Paid 0-0.01-0.15-0.38-0.41
Cash Flow From Investing Activity -0.07-0.010.080.06-0.17
Capex -0.01-0.04-0.01-0.07-0.18
Net Investments 00000
Others -0.070.030.090.120.01
Cash Flow From Financing Activity -0.33-0.31-1.13-1.68-0.27
Net Proceeds from Shares 00.30000
Net Proceeds from Borrowing -1.230.67-0.63-0.030.81
Interest Paid -1.21-1.21-1.21-1.05-1.12
Dividend Paid 00000
Others 2.12-0.060.71-0.600.04
Net Cash Flow 0.120.18-0.170.43-0.36
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17
Ratios
ROE (%)12.7810.965.3813.9411.21
ROCE (%)12.8612.139.9614.0813.29
Asset Turnover Ratio1.041.441.411.051.02
PAT to CFO Conversion(x)0.720.712.351.920.08
Working Capital Days
Receivable Days1319092126154
Inventory Days1088697137128
Payable Days86636794101

Affine Formulations Ltd Stock News

Affine Formulations Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Affine Formulations on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Affine Formulations stood at ₹0.00.
The latest P/E ratio of Affine Formulations as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Affine Formulations as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Affine Formulations is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Affine Formulations is ₹25.14 ( Cr.) .

About Affine Formulations Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.